Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
Use this VIR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VIR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VIR SEC filings page. Lician reads the product cache first so this HTML stays unique to Vir Biotechnology Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VIR income, balance, and cash tables.